We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cypress Returns Fire Against Glaxo Over Zantac

Law360 (July 18, 2007, 12:00 AM EDT) -- A generic drug maker has opposed Glaxo Group Ltd.'s patent claims over ulcer drug Zantac, claiming that the patent is invalid and noninfringed.

Cypress Pharmaceutical Inc. filed counterclaims against Glaxo in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.